Merck & Co., Inc. (TSX:MRK)
Canada flag Canada · Delayed Price · Currency is CAD
32.75
+0.13 (0.40%)
Nov 13, 2026, 4:00 PM EST

Merck & Co. Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
67,37865,01164,16860,11559,28348,704
Revenue Growth
4.89%1.31%6.74%1.40%21.72%17.31%
Gross Profit
50,66750,19649,47044,20042,07735,238
Operating Income
23,69124,46724,88915,97420,49013,893
Net Income
2,45318,25417,11736514,51913,049
Earnings Per Share
0.997.286.740.145.715.14
EPS Growth
-86.91%8.01%4714.29%-97.55%11.15%84.61%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Keytruda/Keytruda Qlex
33,37331,68129,48225,01120,93717,186
Gardasil/Gardasil 9
5,2645,2338,5838,8866,8975,673
Januvia/Janumet
1,8842,5442,2683,3664,5135,288
ProQuad/M-M-R II/Varivax
2,4792,4512,4852,3682,2412,135
Bridion
1,6121,8411,7641,8421,6851,532
Lynparza - Alliance
1,4471,4501,3111,1991,116989
Winrevair
2,2741,443419---
Lenvima - Alliance
1,0981,0531,010960876704
Animal Health
6,7476,3545,8775,6255,5505,568
Other Product
4115158919071,728382
Other
10,78910,44610,0789,95113,7409,247
Revenue (Total)
67,37865,01164,16860,11559,28348,704

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9,65014,56513,6897,09313,1928,096
Total Debt
53,90350,53438,27036,26831,98534,631
Net Cash (Debt)
-44,253-35,969-24,581-29,175-18,793-26,535
Net Cash Growth
------
Net Cash Per Share
-17.88-14.35-9.67-11.45-7.39-10.46

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
18,70316,47221,46813,00619,09514,109
Capital Expenditures
-3,957-4,112-3,372-3,863-4,388-4,448
Free Cash Flow
14,74612,36018,0969,14314,7079,661
Free Cash Flow Growth
13.00%-31.70%97.92%-37.83%52.23%66.22%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
75.20%77.21%77.09%73.53%70.98%72.35%
Operating Margin
35.16%37.64%38.79%26.57%34.56%28.52%
Pretax Margin
7.07%32.41%31.07%3.14%27.74%28.50%
Profit Margin
3.64%28.08%26.67%0.61%24.49%26.79%
FCF Margin
21.88%19.01%28.20%15.21%24.81%19.84%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.7693.2403.0802.9202.7602.600
Dividend Per Share Growth
0%5.20%5.48%5.80%6.15%6.56%
Dividend Yield
2.35%3.07%3.09%2.68%2.49%3.40%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
185.5714.3114.70756.8819.3814.84
P/FCF Ratio
24.8021.1413.9130.2219.1320.04
PS Ratio
5.434.023.924.604.753.98